Inventiva (IVA) Return on Assets (2020 - 2022)

Inventiva (IVA) recorded quarterly Return on Assets of 0.0% in Q2 2022, up 32.73% quarter-over-quarter from 0.0% in Q4 2021, and little changed on a YoY basis from 0.0% in Q2 2021.

Inventiva (IVA) Return on Assets (2020 - 2022) Analysis & Trends

Inventiva's Return on Assets history runs 3 years deep, the most recent figure standing at 0.0% for Q2 2022.

  • In Q2 2022, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM figure through Jun 2022 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.01%, up 1.0% from the prior year.
  • Return on Assets was 0.0% for Q2 2022 at Inventiva, up from 0.0% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.0% in Q2 2022 to a low of 0.01% in Q4 2020.
  • Historically, Return on Assets has averaged 0.0% across 3 years, with a median of 0.0% in 2021.
  • Biggest YoY gain for Return on Assets was 0 bps in 2021; the steepest drop was 0 bps in 2021.
  • A 3-year view of Return on Assets shows it stood at 0.01% in 2020, then surged by 47 bps to 0.0% in 2021, then jumped by 33 bps to 0.0% in 2022.
  • The last three Return on Assets figures came in at 0.0% (Q2 2022), 0.0% (Q4 2021), and 0.0% (Q2 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -0.80%
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -0.01%
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 0.00%
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -0.01%
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - 0.00%
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 0.00%
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 0.00%
9 Abivax 95.45 Bn 95.45 Bn - -0.01%
10 Inventiva 8.93 Mn -259.80 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2022 0.00%
Dec 31, 2021 0.00%
Jun 30, 2021 0.00%
Mar 31, 2021 0.00%
Dec 31, 2020 -0.01%